Th17 plasticity: Pathophysiology and treatment of chronic inflammatory disorders

Current Opinion in Pharmacology

Volumn 17, Issue 1, 2014, Pages 12-16

  Cosmi, Lorenzo ^a,b   Santarlasci, Veronica ^a,b   Maggi, Laura ^a,b   Liotta, Francesco ^a,b   Annunziato, Francesco ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRODALUMAB; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; IXEKIZUMAB; PLACEBO; SECUKINUMAB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; USTEKINUMAB; ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CROHN DISEASE; DRUG EFFICACY; DRUG PROTEIN BINDING; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; TH1 TH2 BALANCE; TH17 CELL; TREATMENT RESPONSE; ANIMAL; CELL LINEAGE; CHRONIC DISEASE; DRUG DESIGN; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINEAGE; CHRONIC DISEASE; CYTOKINES; DRUG DESIGN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; PHENOTYPE; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 84903522281     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.06.004     Document Type: Review

References (40)

1. L. Cosmi, L. Maggi, V. Santarlasci, F. Liotta, and F. Annunziato T helper cells plasticity in inflammation Cytometry A 2013 2234 10.1002/cyto.a.8
2. J.D. Milner, J.M. Brenchley, A. Laurence, A.F. Freeman, B.J. Hill, K.M. Elias, Y. Kanno, C. Spalding, H.Z. Elloumi, and M.L. Paulson et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome Nature 452 2008 773 776 (Pubitemid 351521078)
3. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani Main features of human T helper 17 cells Ann N Y Acad Sci 1284 2013 66 70 10.1111/nyas.12075
4. P. Miossec, and J.K. Kolls Targeting IL-17 and TH17 cells in chronic inflammation Nat Rev Drug Discov 11 2012 763 776
5. C.Y. Kao, Y. Chen, P. Thai, S. Wachi, F. Huang, C. Kim, R.W. Harper, and R. Wu IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signalling pathways J Immunol 173 2004 3482 3491 (Pubitemid 39142059)
6. Y. Chen, P. Thai, Y.H. Zhao, Y.S. Ho, M.M. DeSouza, and R. Wu Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop J Biol Chem 278 2003 17036 17043 (Pubitemid 36799579)
7. I.I. Ivanov, B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman The orphan nuclear receptor RORct directs the differentiation program of proinflammatory IL-17+T helper cells Cell 126 2006 1121 1131
8. E.V. Acosta-Rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 2007 639 646 (Pubitemid 46785128)
9. F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, and F. Frosali et al. Phenotypic and functional features of human Th17 cells J Exp Med 204 2007 1849 1861 (Pubitemid 47240944)
10. L. Cosmi, R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, and R. Angeli et al. Human interleukin-17-producing cells originate from a CD161+ CD4+ T-cell precursor J Exp Med 205 2008 1903 1916
11. V. Santarlasci, L. Maggi, M. Capone, V. Querci, L. Beltrame, D. Cavalieri, E. D'Aiuto, R. Cimaz, A. Nebbioso, and F. Liotta et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion Immunity 36 2012 201 214
12. V. Santarlasci, L. Maggi, A. Mazzoni, M. Capone, V. Querci, M.C. Rossi, L. Beltrame, D. Cavalieri, R. De Palma, and F. Liotta et al. IL-4-induced gene 1 maintains high Tob1 expression which contributes to TCR unresponsiveness in human T helper 17 cells Eur J Immunol 2013 10.1002/eji.201344047
13. E.V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 8 2007 942 949 (Pubitemid 47300008)
14. V. Santarlasci, L. Maggi, M. Capone, F. Frosali, V. Querci, R. De Palma, F. Liotta, L. Cosmi, E. Maggi, and S. Romagnani et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells Eur J Immunol 39 2009 207 215
15. K. Ghoreschi, A. Laurence, X.P. Yang, C.M. Tato, M.J. McGeachy, J.E. Konkel, H.L. Ramos, L. Wei, T.S. Davidson, and N. Bouladoux et al. Generation of pathogenic T(H)17 cells in the absence of TGF-b signaling Nature 467 2010 967 971
16. F. Sallusto, C.E. Zielinski, and A. Lanzavecchia Human Th17 subsets Eur J Immunol 42 2012 2215 2220
17. C.E. Zielinski, F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β Nature 484 2012 514 518
18. L. Maggi, V. Santarlasci, M. Capone, M.C. Rossi, V. Querci, A. Mazzoni, R. Cimaz, R. De Palma, F. Liotta, and E. Maggi et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells Eur J Immunol 42 2012 3180 3188
19. N. Martin-Orozco, Y. Chung, S.H. Chang, Y.H. Wang, and C. Dong Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells Eur J Immunol 39 2009 216 224
20. D. Bending, H. De la Pena, M. Veldhoen, J.M. Phillips, C. Uyttenhove, B. Stockinger, and A. Cooke Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice J Clin Invest 119 2009 565 572
21. K. Nistala, S. Adams, H. Cambrook, S. Ursu, B. Olivito, W. de Jager, J.G. Evans, R. Cimaz, and M. Bajaj-Elliott et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment Proc Natl Acad Sci USA 107 2010 14751 14756
22. L. Cosmi, R. Cimaz, L. Maggi, V. Santarlasci, M. Capone, F. Borriello, F. Frosali, V. Querci, G. Simonini, and G. Barra Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis Arthritis Rheum 63 2011 2504 2515
23. L. Maggi, R. Cimaz, M. Capone, V. Santarlasci, V. Querci, G. Simonini, F. Nencini, F. Liotta, S. Romagnani, and E. Maggi et al. Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis Arthritis Rheumatol 2014 10.1002/art.3835
24. L. Maggi, M. Capone, F. Giudici, V. Santarlasci, V. Querci, F. Liotta, F. Ficari, E. Maggi, F. Tonelli, F. Annunziato, and L. Cosmi CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy Int Arch Allergy Immunol 161 2012 81 86
25. L. Cosmi, L. Maggi, V. Santarlasci, M. Capone, E. Cardilicchia, F. Frosali, V. Querci, R. Angeli, A. Matucci, and M. Fambrini et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4 J Allergy Clin Immunol 125 2010 222 230
26. D.C. Newcomb, and R.S. Peebles Jr. Th17-mediated inflammation in asthma Curr Opin Immunol 25 2013 755 760
27. Y.H. Wang, K.S. Voo, B. Liu, C.Y. Chen, B. Uygungil, W. Spoede, J.A. Bernstein, D.P. Huston, and Y.J. Liu A novel subset of CD4+T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma J Exp Med 207 2010 2479 2491
28. L. Cosmi, F. Liotta, E. Maggi, S. Romagnani, and F. Annunziato Th17 cells: new players in asthma pathogenesis Allergy 66 2011 989 998
29. Y. Zheng, D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis Nature 445 2007 648 651 (Pubitemid 46232884)
30. M.A. Lowes, T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L.C. Zaba, A.S. Haider, E.P. Bowman, and J.G. Krueger Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 2008 1207 1211 (Pubitemid 351543220)
31. C. Leonardi, R. Matheson, C. Zachariae, G. Cameron, L. Li, E. Edson-Heredia, D. Braun, and S. Banerjee Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis N Engl J Med 366 2012 1190 1199
32. K.A. Papp, C. Leonardi, A. Menter, J.P. Ortonne, J.G. Krueger, G. Kricorian, G. Aras, J. Li, C.B. Russell, E.H. Thompson, and S. Baumgartner Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis N Engl J Med 366 2012 1181 1189
33. D.A. Martin, M. Churchill, L. Flores-Suarez, M.H. Cardiel, D. Wallace, R. Martin, K. Phillips, J.L. Kaine, H. Dong, and D. Salinger et al. A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis Arthritis Res Ther 15 2013 R164 10.1186/ar4347
34. W. Hueber, B.E. Sands, S. Lewitzky, M. Vandemeulebroecke, W. Reinisch, P.D. Higgins, J. Wehkamp, B.G. Feagan, M.D. Yao, and M. Karczewski et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Gut 61 2012 1693 1700
35. G.G. Krueger, R.G. Langley, C. Leonardi, N. Yeilding, C. Guzzo, Y. Wang, L.T. Dooley, and M. Lebwohl A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis N Engl J Med 356 2007 580 592 (Pubitemid 46220818)
36. W.J. Sandborn, B.G. Feagan, R.N. Fedorak, E. Scherl, M.R. Fleisher, S. Katz, J. Johanns, M. Blank, and P. Rutgeerts A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease Gastroenterology 135 2008 1130 1141
37. W.W. Busse, S. Holgate, E. Kerwin, Y. Chon, J. Feng, J. Lin, and S.L. Lin Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma Am J Respir Crit Care Med 188 2013 1294 1302
38. B.P. Fauber, and S. Magnuson Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc) J Med Chem 2014 (Epub ahead of print)
39. D.M. Kofler, A. Marson, M. Dominguez-Villar, S. Xiao, V.K. Kuchroo, and D.A. Hafler Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells J Clin Invest 124 2014 2513 2522
40. J.R. Fergusson, V.M. Fleming, and P. Klenerman CD161-expressing human T cells Front Immunol 2 2011 36